– Data Showed LEQEMBI Slowed Clinical Decline by 1.75 Points on CDR-SB at Four Years Compared to the Natural History of Alzheimer’s Disease – 56% of Patients with Low Tau Continued to Demonstrate Improved Cognitive and Daily Living Function at Four Years TOKYO and CAMBRIDGE, Mass., July 31, 2025 – (JCN Newswire via SeaPRwire.com) –... » read more
TOKYO and CAMBRIDGE, Mass., July 31, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”)and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher,“Biogen”) announced today that results on investigational maintenance therapy with subcutaneous autoinjector (SCAI) of lecanemab-irmb (U.S. brand name: LEQEMBI®), an anti-amyloid beta (AB) protofibril*... » read more
TOKYO and CAMBRIDGE, Mass., July 31, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito,“Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A.Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-AB protofibril* antibody, was... » read more
TOYOTA CITY, July 30, 2025 – (JCN Newswire via SeaPRwire.com) – Toyota Motor Corporation announces its sales, production, and export results for June 2025 as well as the cumulative total from January to June 2025, including those for subsidiaries Daihatsu Motor Co., Ltd. and Hino Motors, Ltd. For more details, please see the link below (detailed... » read more
Santa Clara, CA, July 29, 2025, (ACN Newswire via SeaPRwire.com) – Meshy.ai, the world’s leading AI-powered 3D content generation platform, has launched the Meshy 5 Preview, offering early access to the next generation of AI 3D model generator. Built on the strong foundation of Meshy 4, this preview version introduces smarter generation tools, enhanced image... » read more
TOKYO, July 30, 2025 – (JCN Newswire via SeaPRwire.com) – Sharp Corporation has reached an agreement with Mitsubishi Chemical Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Manabu Tsukimoto), the National Institute of Information and Communications Technology (NICT) (Headquarters: Koganei City, Tokyo; President: Hideyuki Tokuda), and TECHLAB Co., Ltd. (Headquarters: Tama City, Tokyo; President: Hiroshi Hatakeyama) to collaboratively... » read more
Mitsubishi Heavy Industries aims to integrate DCIM (Data Center Infrastructure Management) into its One-stop solutions portfolio to offer digital services to data centers The combination delivers a comprehensive view of data center infrastructure, enabling enhanced visibility, elevated operational efficiency and optimized energy consumption TOKYO, July 29, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Heavy... » read more
Osaka, Japan, July 29, 2025 – (JCN Newswire via SeaPRwire.com) – Osaka Prefecture has finalized the detailed program for the OSAKA JAPAN SDGs Forum to be held on Friday, September 5, 2025. Under the Osaka SDGs Vision (formulated in 2020), Osaka Prefecture has set the goal of becoming a leading “SDGs advanced city” that contributes to... » read more
TOKYO, July 29, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its in-house discovered tyrosine kinase inhibitor, “LENVIMA®” (generic name: lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial chemoembolization (TACE) has been approved by the National Medical Products Administration (NMPA) of... » read more
Olympus to take a significant equity stake in Swan EndoSurgical with a combined initial investment of at least $65 million. Swan EndoSurgical to develop an innovative endoluminal robotic system for less invasive therapeutic treatments. The total combined funding could reach up to $458 million if pre-agreed milestones are met and the program reaches term. TOKYO,... » read more
TOKYO, July 25, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has been included in the FTSE4Good Index Series for the 24th consecutive year since its initial inclusion in 2002. The FTSE4Good Index Series is a global index series for socially responsible investment. The... » read more
Over 100 attendees gathered at Suntec Singapore Convention & Exhibition Centre forONERHT Foundation’s 8th GAIL Forum 2025 Forum featured high-level discussions on a wide range of topics including green leadership,ESG regulatory frameworks, carbon markets as well as the role of artificial intelligence (AI) inadvancing a sustainable future SINGAPORE, July 24, 2025 – (ACN Newswire via... » read more
Kawasaki and Nagoya, Japan, July 24, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu Limited and Nagoya University, a member of the Tokai National Higher Education and Research System (THERS), have jointly developed a technology to encourage the use of new transportation services and eliminate transportation gaps. The “social acceptance model-based simulation (SAMSIM)” simulates how... » read more
TOKYO, Japan, July 24, 2025 – (JCN Newswire via SeaPRwire.com) – Honda Motor Co., Ltd. (Honda) today revealed some details of how it will support the World Athletics Championships Tokyo 25 (WCH Tokyo 25), which will be held from September 13 through 21, 2025. As an official global partner, Honda will contribute to the sustainability objectives... » read more
– Rationalization of domestic production technologies and strengthening of the system in Japan for manufacturing divertor outer vertical targets for ITER– Seeking to contribute to the ITER Project and provide components for the prototype reactor for fusion energy and startup machines TOKYO, July 23, 2025 – (JCN Newswire via SeaPRwire.com) – Hitachi, Ltd. (TSE:6501, “Hitachi”)... » read more
Showcasing a prototype LEO satellite communication terminal (*1) enabling high-speed, high-capacity communication in areas with limited cellular coverage TOKYO, July 23, 2025 – (JCN Newswire via SeaPRwire.com) – Sharp Corporation (herein after “Sharp”) will exhibit at the 2nd SPEXA – International Space Business Expo, held at Tokyo Big Sight (Koto-ku, Tokyo) from Wednesday, July 30 to... » read more
TOKYO, July 23, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and KYORIN Pharmaceutical Co., Ltd.(Headquarters: Chiyoda-ku, Tokyo, President and CEO: Yutaka Ogihara, “KYORIN”) announced today that Eisai (Thailand) Marketing Co., Ltd. (“Eisai Thailand”), a subsidiary of Eisai, has launched overactive bladder treatment Beova® Tablets (generic name vibegron)... » read more
SAN DIEGO, July 23, 2025 – (JCN Newswire via SeaPRwire.com) – Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, announced today that its San Diego laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification. This significant milestone enables Crown Bioscience to... » read more
TOKYO, July 22, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced the termination of its engine business operation at Shenyang Aerospace Mitsubishi Motors Engine Manufacturing Co., Ltd. (hereinafter, SAME) in China and has terminated the joint venture partnership. Established in August 1997, SAME began engine production in 1998 and... » read more
Latest findings from Eisai’s robust Alzheimer’s disease (AD) pipeline include results from lecanemab longterm data, an immunoassay for measuring amyloid-B protofibrils in cerebrospinal fluid, and asubcutaneousl form of lecanemab for continued treatment of AD AD is a progressive, relentless disease caused by a continuous underlying neurotoxic process that begins before and continues after plaque deposition... » read more